SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Imagion Biosystems Limited (IBXXF) .
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
Overall SharesGrow Score: 25/100 with 0/7 criteria passed.
SharesGrow 7-Criteria Score
✗
HEALTH
0/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — IBXXF
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.00
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-0.02
Book Value / Share$0.00
Revenue / Share$0.00
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$-0.01 |
$12.00 |
$-1.03M |
-8620641.7% |
| 2017 |
$-0.04 |
$20.1K |
$-7.79M |
-38775.3% |
| 2018 |
$-0.04 |
$191.48K |
$-8.35M |
-4359.7% |
| 2019 |
$-0.61 |
$410.85K |
$-5.47M |
-1330.4% |
| 2020 |
$-0.42 |
$205.72K |
$-7.8M |
-3789.2% |
| 2021 |
$-0.33 |
$232.87K |
$-8.64M |
-3710% |
| 2022 |
$-0.35 |
$473.43K |
$-9.81M |
-2071.9% |
| 2023 |
$-0.41 |
$1.37M |
$-12.47M |
-912.2% |
| 2024 |
$-0.05 |
$2.67M |
$-2.07M |
-77.6% |
| 2025 |
$-0.02 |
$0.00 |
$-4.31M |
- |
